Cargando…
Schlafen 12 Slows TNBC Tumor Growth, Induces Luminal Markers, and Predicts Favorable Survival
SIMPLE SUMMARY: This study indicates that we could develop a prognostic predictor and new targets for TNBC treatment by increasing the expression levels of the protein SLFN12 and through targeting the SLFN12 gene signature. Therapies that would target SLFN12 and its corresponding gene signature coul...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856841/ https://www.ncbi.nlm.nih.gov/pubmed/36672349 http://dx.doi.org/10.3390/cancers15020402 |